Video & Transcript : 'clinical trial' :
Page 12 of 384
CA
California 2025-2026 Regular Session
Senate Health Committee Apr 8th, 2026
Transcript Highlights:
- This issue is repeating itself at clinics across the state, This issue is repeating itself at clinics
- Usually it's by plea or a jury trial, that the ...or a jury trial, that the death certificate should
- Our objective is that clinical nurse specialists should be included in the bill.
- There are more than 3,000 clinical nurse specialists in California.
- That there are more than 3,000 clinical nurse specialists in California.
Summary:
The Senate Committee on Health heard several bills focused on Medi-Cal access, HIV prevention, death certificate amendments, caregiver certification, advance care planning, and sugar-sweetened beverage labeling. SB 1422 by Senator Durazo would restore Medi-Cal access for income-eligible undocumented adults beginning January 1, 2027. The author and many supporters argued the enrollment freeze shifts costs to counties and hospitals, worsens health outcomes, and undermines California’s prior coverage gains. County, labor, health, immigrant-rights, and provider groups testified in support; there was no opposition. Committee members generally expressed support but also raised concerns about funding and the need for new revenue sources. The bill was discussed while the committee lacked quorum, so no vote was taken at that time.
The committee also heard SB 1023 on PrEP access, SB 1071 on death certificate amendments after homicide findings, SB 1057 on criminal-history review for CNA and home health aide certification, and SB 1088 on POLST and advance care planning updates. SB 1023 would require insurers that cover injectable PrEP under the medical benefit to also cover it through the pharmacy benefit; supporters said this would reduce administrative barriers and improve access, while health plans and insurers opposed it as an unnecessary mandate that could blur benefit design lines. SB 1071 would allow next of kin to amend a death certificate’s manner of death to homicide after a final court determination; families and law enforcement supported it as a matter of truth and closure, while coroners opposed it as blurring medical and legal findings and potentially distorting public health data. SB 1057 would replace automatic denial with individualized review for certain convictions in CNA and home health aide certification, and SB 1088 would modernize POLST/DNR rules, including electronic signatures, out-of-state recognition, and clarifying who may sign; both drew support, though clinical nurse specialists opposed SB 1088 because they were not included as authorized signers. Several of these bills were heard without quorum, so no votes were taken during the discussion.
After quorum was established, the committee heard SB 869 by Senator Weber-Pierce, which would require large chain restaurants to display a clear added-sugar icon next to beverages exceeding 50% of the daily recommended limit. The author and supporters, including the American Diabetes Association and an emergency physician, said consumers need simple, visible information at the point of purchase to better understand health risks tied to sugary drinks. The bill was framed as a public health transparency measure aimed at diabetes, obesity, and other chronic disease prevention. The transcript ends during testimony on SB 869, before any final committee action or vote is shown.
CA
Transcript Highlights:
- There are public clinical reports.
- Overdose implies also that it can be prescribed in clinical trials and that.
- So I just want to be clear... ...that it can be prescribed in clinical trials and that.
- When you have a substance that hasn't undergone clinical trials to establish safety, where it goes from
- That claim is based on zero clinical trials and zero observational studies.
Committee:
Senate Health
Summary:
The committee held an informational hearing on kratom and 7-hydroxymitragynine (7-OH), focusing on public health risks, overdose deaths, and regulatory gaps in California. The chair opened by noting that FDA and CDPH consider kratom and 7-OH products unlawful for consumption, yet they remain widely sold in smoke shops, vape stores, gas stations, and convenience stores. The hearing was framed as part of ongoing legislative work, including a future review of AB 1088, and members emphasized the need to weigh potential benefits against risks and consider whether stronger safeguards are needed.
Expert testimony from a toxicology professor and several public health and medical officials described kratom as a plant with multiple alkaloids, with 7-OH identified as the more potent opioid-like compound associated with tolerance, dependence, withdrawal, and respiratory depression. CDPH reported 362 kratom-related overdose deaths in California from 2019 to 2023 and 15 deaths involving 7-OH, while Los Angeles County officials described unexplained deaths in young adults that led them to expand toxicology testing and identify 7-OH as a common factor. County and state public health representatives said they have issued advisories, contacted retailers, removed products from shelves, and taken enforcement actions, but they stressed that local enforcement is patchy, under-resourced, and limited by unclear jurisdiction and lack of testing capacity.
Medical witnesses said patients are presenting with 7-OH dependence and withdrawal in ways similar to fentanyl-related cases, sometimes requiring buprenorphine, methadone, or repeated naloxone. They argued that unregulated retail sales and misleading marketing make the products especially risky, and that a statewide framework would be more effective than a patchwork of local ordinances. Some officials said the safest current policy is to keep kratom and 7-OH unlawful for consumption, while others said any new regulation would need resources, packaging rules, and clearer authority for enforcement.
Industry and consumer advocates urged the committee to distinguish natural kratom leaf from concentrated or synthetic 7-OH products. They argued that kratom leaf has long-standing use, that 7-OH should be targeted rather than the whole plant, and that regulation should focus on age limits, labeling, testing, serving-size caps, and restrictions on adulterated products rather than prohibition. Several speakers warned that bans could push demand to the black market and reduce access for people using the products for pain relief or harm reduction, while critics of the industry said the products are being marketed deceptively and that more comprehensive regulation is needed.
TX
Transcript Highlights:
- We might engage in a randomized control trial, and ideally, that would be a double-blinded trial to really
- More than 50 randomized clinical trials show the huge range of benefits of ivermectin, not just for COVID
- You mentioned the World Health Organization and 50 clinical trials.
- And as far as a clinical trial...
- So it's totally a moving target because there continue to be more and more trials.
Committee:
House Public Health
KY
Kentucky 2026 Regular Session
House Standing Committee on Veterans, Military Affairs, and Public Protection (2-3-26)
Veterans, Military Affairs, & Public Protection
Transcript Highlights:
- So I came recommended by the clinic.
- We've completed 28 medical clinical trials since 2007. Eight of those were focused on PTSD vets.
- Eight trials, 393 subjects, 40 to 60 HBOT treatments.
- Eight trials, 393 subjects, resounding.
- trials we have on the record, been published peer-reviewed.
AZ
Transcript Highlights:
- the Board of Dental Examiners does not have jurisdiction over an accredited dental school and their clinic
- Their clinics are not a business entity was not included in the striker, and so we will be asking that
- Allied Health would do the training, and it would start with clinical training, because it's important
- And so with this program, you get on the ground, people could start their program and their clinical
- “Cleo waiver tests—Cleo waivers are things that say you don’t need a clinical laboratory, laboratory
Bills:
SB1041 , SB1088 , SB1118 , SB1128 , SB1168 , SB1176 , SB1189 , SB1207 , SB1250 , SB1272 , SB1274 , SB1286 , SB1428 , SB1457 , SB1461 , SB1503 , SB1519 , SB1537 , SB1582 , SB1618 , SB1654 , SB1713 , SB1827 , SCR1012 , SCR1020
Keywords:
electronic monitoring, nursing care, assisted living, resident rights, privacy, consent, surveillance, cybersecurity, homeland security, artificial intelligence, state appropriation, VPN security, zero trust, housing, zoning, middle housing, urban development, duplexes, triplexes, fourplexes
AZ
Transcript Highlights:
- That's not the clinical process that Access dictates for the health plans right now.
- Today I'm here to support SB 1672, codifying medication trials to two medications.
- I think it's clinical practice to always start with the least expensive medication first.
- I can't speak to that... we do clinical trials in our office, and we know, we know...
- I can't speak that, that, you know, we do clinical trials in our office, and we know, we know, “I can
Bills:
SB1052 , SB1115 , SB1118 , SB1120 , SB1121 , SB1124 , SB1171 , SB1172 , SB1174 , SB1175 , SB1214 , SB1233 , SB1235 , SB1316 , SB1345 , SB1372 , SB1399 , SB1458 , SB1494 , SB1496 , SB1564 , SB1602 , SB1621 , SB1628 , SB1630 , SB1631 , SB1668 , SB1672 , SB1814 , SB1821
Committees:
House Health & Human Services , House House Health & Human Services Committee of Reference
Keywords:
assisted living, health care, hyperbaric oxygen therapy, physician orders, informed consent, AHCCCS, remote work, state agency, employment, public health, housing, zoning, middle housing, urban development, duplexes, triplexes, fourplexes, townhomes, historic preservation, radiation protection
AL
Alabama 2025 Regular Session
Alabama Senate Children and Youth Health Committee Apr 9th, 2025
Children and Youth Health
Transcript Highlights:
- We have some of the best research institutes and clinical trials... ...research institutes.
- Clinical trials need to be studied.
- So the research in Birmingham has studied just about every pharmaceutical clinical trial.
Bills:
SB274
Committee:
Senate Children and Youth Health
NM
Transcript Highlights:
- President, I can't speak for trial attorneys.
- Ultimately, we found out later in a 2015 randomized trial, because we wanted a lot of data, Mr.
- The trial randomized high-risk infants to early exposure to peanuts versus delaying the exposure.
- The trial found that the early exposure was far better for kids.
- We will be assisting rural hospitals and rural clinics. clinics, and the department has indicated they
WA
Washington 2025-2026 Regular Session
House Health Care & Wellness Jan 16th, 2026
Transcript Highlights:
- Washington's Medicaid program currently covers up to three monthly IVIG therapies when a trial of two
- When clinically appropriate trials of two less intensive treatments were completed and were not effective
- Health carriers may require that a patient be clinically re-evaluated at three-month intervals.
- I co-founded the Stanford PANS Clinic, which is now called the Immune Behavioral Health Clinic at Stanford
- We know patients who have access to their information have better clinical outcomes.
Summary:
The committee heard testimony on three health care bills. HB 1496 would cap charges for electronically stored medical records at $50 for patients and certain authorized recipients, while removing a free-copy provision tied to SSI/SSDI appeals and changing attorney fee language to “prevailing patient.” Supporters, including patient advocates, attorneys, and injured workers, said current record fees can reach thousands of dollars and block access to justice; opponents, including hospitals, home care providers, and records vendors, argued the bill would not cover the labor and HIPAA compliance work involved in large third-party requests and could shift costs to providers and patients. The bill remained in hearing with testimony continuing after the committee moved through other bills.
HB 2182 would change how the Department of Corrections distributes its stockpile of mifepristone and misoprostol, removing the requirement that the medications be sold at cost plus a $5 fee and instead allowing, but not requiring, payment while directing DOC and the Department of Health to coordinate distribution to providers and facilities. The prime sponsor and supporters said the bill is needed so the state’s stockpile does not go unused or expire and to remove barriers to access for abortion and miscarriage care; opponents argued the bill subsidizes abortion, raises legal and taxpayer concerns, and should be rejected. Public testimony on HB 2182 was closed after hearing from both supporters and opponents.
HB 2196 would require certain fully insured health plans to cover IVIG for PANS and PANDAS, with initial and medically necessary follow-up courses, and would bar denials based on prior treatment, age, out-of-state care when unavailable in Washington, or treatment guidelines that only address psychiatric symptoms. The sponsor, families, and physicians described severe, sudden-onset symptoms in children and said IVIG can be life-changing after other treatments fail, while insurers warned the mandate could add to already rising premiums and noted the treatment can be very expensive. HB 2242 would shift vaccine and preventive-service recommendation authority from federal bodies to the Department of Health, while preserving no-cost coverage for preventive services and updating the reference date for protected services; the governor, insurance commissioner, public health officials, and many physicians supported it as a way to preserve access amid federal instability and rising vaccine-preventable disease, while questions focused on whether the bill would change school or daycare requirements, which staff said it would not.
TX
Texas 89th Regular
Appropriations - S/C on Articles VI, VII, & VIII Feb 27th, 2025
Appropriations - S/C on Articles VI, VII, & VIII
Transcript Highlights:
- trials.
- trials, field trials begun in the 2024-2025 biennium that was originally appropriated $316,000.
- Rider 9, cattle fever tick mitigation clinical trials.
- This is the cattle fever tick trials discussed previously.
- Drop syndrome, the main clinical sign of which was a decrease in milk production.
Summary:
The committee met with a quorum present to hear Article VI Natural Resources agency budget recommendations, beginning with the Railroad Commission. LBB staff summarized the commission’s 2026-27 base recommendation at $458.7 million, down from the prior biennium, with an increased FTE cap. The presentation highlighted reduced federal IIJA funding, volatility in oil and gas regulation account 5155, continued support for IT modernization, and rider changes. The commission’s major exceptional items were then presented, including requests for produced water and injection data reporting, an authorized pit registration system, regulatory filing/permitting upgrades, an underground injection well investigation team, site remediation support, and especially $100 million for orphan well plugging. Members asked about biennium-to-biennium comparisons, salary biennialization, the scale of orphan well risks, federal funding delays, bonding, and whether the state should rely more on industry or general revenue for plugging costs. Commission leadership explained that orphan wells can threaten water and public safety, that plugging costs have risen sharply, and that current funding is insufficient to keep up with emergency wells and the backlog; they also said the agency is moving to cloud-based systems with cybersecurity protections and that the proposed performance measure may need adjustment if funding does not increase.
The Railroad Commission testimony was followed by LBB and agency testimony for the Texas Animal Health Commission. LBB described a $42 million recommendation for 2026-27, an increase overall, but with a reduced FTE cap due to turnover and salary reallocation. The recommendation maintained funding for cattle fever tick work, chronic wasting disease, lab testing through an MOU with Texas A&M’s veterinary diagnostic lab, and a new $5 million spay-and-neuter pilot program, while deleting a capital budget rider and adjusting riders tied to entry point inspection stations and clinical trials. Agency leadership then outlined the commission’s mission to protect livestock health and the state’s $22 billion animal industry, and described major disease threats including highly pathogenic avian influenza, cattle fever ticks, New World screwworm, and chronic wasting disease. Their exceptional items focused on recruiting and retaining veterinarians, replacing fleet vehicles, creating an ectoparasite identification lab, adding field staff and IT support, improving records and epidemiology reporting, strengthening central administration, supporting secure food supply planning, expanding chronic wasting disease work, and staffing the new spay-and-neuter program. Members asked about field identification of ticks, the use of disinfectants and PPE, fleet management, the scale of cattle fever tick risk, and chronic wasting disease; the agency explained its current inspection and lab-confirmation process, its reliance on field disinfecting and biosecurity, and the need for more staff and better data systems to keep pace with growing workloads and disease threats.
US
US Federal 2025-2026 Regular Session
Hearings to examine S.222, to amend the Richard B. Russell National School Lunch Act to allow schools that participate in the school lunch program to serve whole milk. Apr 1st, 2025 at 09:00 am
Agriculture, Nutrition, and Forestry Committee
Transcript Highlights:
- Ayoub directed the Nutrition Clinic as part of the Children's Evaluation Program. and Rehabilitation
- He's also a registered dietitian and nutritionist, with over 30 years of clinical experience, working
- For 33 years, I directed the Nutrition Clinic as part of the Children's Evaluation and Rehabilitation
- I know my kids in my clinic have said that they find skim milk watery.
- The milk that we were ordering increased by 50% and the waste decreased by 95% during the trial years
Bills:
SB222
Keywords:
whole milk, school lunch, school meals, National School Lunch Program, Richard B. Russell National School Lunch Act, Child Nutrition Act, USDA, nutrition standards, dairy, nonfat milk, low-fat milk, reduced-fat milk, lactose-free milk, nondairy beverages, plant-based milk, milk substitution, parental consent, legal guardian, food allergies, allergic reaction
Summary:
This meeting of the committee focused primarily on the Whole Milk for Healthy Kids Act, S222, which aims to permit schools to offer a fuller range of milk options, including whole, reduced, and low-fat varieties, that have garnered bipartisan support. Chairman Bozeman opened the session by highlighting concerns over children's nutrition and the obesity epidemic, emphasizing the significance of nutritious school meals in addressing these issues. Experts from various organizations were invited to discuss the implications of this bill as well as the current challenges facing school meal programs, including budget constraints and food supply issues. The meeting included passionate testimonies about the direct impacts of current dietary guidelines and federal funding reductions affecting schools' abilities to provide healthy meal options.
TX
Texas 89th Regular
S/C on Disease Prevention & Women's & Children's Health Apr 3rd, 2025
S/C on Disease Prevention & Women's & Children's Health
Transcript Highlights:
- The bill also creates a kidney health clinic and a kidney health clinical trials registry to keep patients
- and families informed of research and trial opportunities.
- The power of those two accessing this would be a registry, a place where clinical trials could be placed
- A place where all of that work that is being done, those clinical trials, that advocacy... the free screenings
- After choosing not to continue with the phase two clinical trial, CPS filed a court order to remove my
AZ
Arizona 2026 Regular Session
01/28/2026 - Senate Judiciary and Elections
Transcript Highlights:
- One, when the clinical team says, 'We're going to release this person early,' One, when the clinical
- The clinic often, as I said, failed to renew his court-ordered treatment.
- His clinic was supposed to be supervising.
- His clinic had failed to renew it. We were unaware it had expired.
- His clinics had to petition him all over again for involuntary hospitalization, where... ...clinics had
Summary:
The Judiciary and Elections Committee approved the January 21, 2026 minutes and held SB 1208. It then heard SB 1211, which would allow victims of felony aggravated harassment involving domestic violence to seek a lifetime injunction against a convicted defendant. Supporters from victim advocacy organizations and a survivor described the bill as an important safety measure that would reduce repeated court appearances and trauma. The committee voted 7-0 to give SB 1211 a do pass recommendation.
The committee next considered SB 1239, which removes the statute of limitations for failing to register as a sex offender or providing false registration information. The sponsor said the bill closes a public-safety loophole and was requested by DPS, while opponents argued existing warrant procedures already address the issue and raised due process concerns. After discussion, the committee voted 4-3 to recommend SB 1239 do pass.
SB 1240 would exclude probationers convicted of dangerous crimes against children from the probation incentive payment formula. The sponsor tied the bill to a recent child sexual assault case and said the change would keep those cases separate from probation performance incentives; defense attorneys warned it could discourage treatment and push more people into prison. The committee voted 4-3 to recommend SB 1240 do pass. The committee also heard and approved SB 1095, as amended, which bans gender transition procedures and referrals for minors and restricts public funding and facilities for such care; supporters called it necessary child protection, while opponents said it was discriminatory. The committee then heard SB 1243 and SB 1244, both related to court-ordered mental health treatment. SB 1243 adds notice to guardians and lets them seek continued treatment, while SB 1244 creates a continuing court-ordered treatment process after repeated annual reviews. Supporters, including family members of seriously mentally ill patients, said the bills would close gaps and prevent dangerous lapses in care; opponents raised due process concerns and warned about expanded involuntary treatment. Both bills received do pass recommendations, with SB 1243 passing 7-0 and SB 1244 passing after amendment and roll call vote.
LA
Louisiana 2026 Regular Session
Commerce May 20th, 2026
Commerce, Consumer Protection, and International Affairs
Transcript Highlights:
- I'll share one example from a recent legal clinic I participated in.
- HB 1223 is a bill that is trying to encourage more clinical trials in Louisiana.
- , speed is what matters the most as far as getting trials to come to Louisiana.
- So that's not specifically in the bill, but it is true that one of the limitations in clinical trials
- You have to have a specialist who can oversee the trial.
Summary:
The committee took up several House measures. HCR 66, as amended, asked Louisiana Economic Development and the Governor’s Office of Rural Development to study rural parish assets, infrastructure, workforce, and development opportunities, and it was moved forward without objection. HB 387, a clarification to allow the fire marshal’s office to review architectural and engineering plans equally, also passed favorably without objection. HB 1223, which would have LED promote Louisiana’s clinical trial capacity and adjust internal review board processes, was amended and moved favorably. HB 950, aimed at helping older adults recognize and avoid fraud through materials and resources from the Office of Elderly Affairs, was reported favorably. HB 975, a routine measure to recreate the Public Service Commission, was also reported favorably. HB 1186, which would create a more uniform statewide building code and licensing system for inspectors, was amended and moved favorably. HB 1222, described as a Grocery Initiative Act to let LED identify ways to address food deserts and food insecurity, was introduced near the end of the meeting.
The most extensive debate centered on HB 617, a consumer transparency bill requiring mandatory fees to be included in upfront pricing. The author said the bill was intended to curb hidden fees and help consumers compare prices, with examples such as hotel resort fees and automatic restaurant service charges. Supporters argued it would improve transparency, while opponents from grocery, restaurant, hotel, housing, retail, and business groups said the bill was too broad, vague about terms like “total price,” unclear on enforcement and penalties, and could create compliance burdens and litigation risk, especially for small businesses. Housing advocates opposed the bill’s housing carve-out, arguing it could weaken renters’ ability to bring unfair-practice claims. Senator Morris moved to defer HB 617, and the committee agreed without objection.
The committee also heard lengthy testimony on HB 797, which would create a Bayou Gold certification for certain transactional gold vendors that meet state-defined standards such as segregation, insurance, and nearby storage. The sponsor said the goal was to give consumers confidence and encourage vendors to keep gold closer to Louisiana, while critics argued the program would amount to a state endorsement of private companies, create misleading consumer impressions, and expose the state to confusion or liability. The bill drew opposition from the Sound Money Defense League and others, but the committee ultimately reported HB 797 favorably, with the understanding it still had to go to Finance. HB 1228, a hearing-aid cleanup bill updating definitions, contracts, testing periods, and licensing rules, was also moved favorably without objection.
LA
Louisiana 2026 Regular Session
Commerce May 20th, 2026
Commerce, Consumer Protection, and International Affairs
Transcript Highlights:
- I'll share one example from a recent legal clinic I participated in.
- HB 1223 is a bill that is trying to encourage more clinical trials in Louisiana.
- , speed is what matters the most as far as getting trials to come to Louisiana.
- trials is having the specialist.
- You have to have a specialist who can oversee the trial.
Summary:
The Senate Commerce Committee met on April 20, approved the prior meeting minutes, and then heard a series of bills and resolutions. It first advanced H. CR 66, which directs Louisiana Economic Development, working with the Governor’s Office of Rural Development, to study rural parish economic assets, infrastructure, workforce, and development opportunities. The committee also moved HB 387, a clarification allowing the fire marshal to review architectural and engineering plans equally, and HB 1223, which seeks to promote clinical trials in Louisiana by having LED market the state’s research capacity and by adjusting internal review board procedures. HB 1228, a cleanup bill for hearing aid dealers that updates definitions, contracts, testing periods, licensing, and related requirements, was also reported favorably, as was HB 950, which would create an elderly consumer perception program through the Office of Elderly Affairs to help seniors recognize scams and fraud.
The committee spent the most time on HB 617, a broad “hidden fees” consumer transparency bill. The author and supporters said it would require mandatory fees to be included in upfront pricing so consumers can make informed choices, while opponents from grocery, restaurant, hotel, housing, retail, and business groups argued the bill was vague, overly broad, and likely to create compliance burdens and litigation risk. Housing advocates objected to the bill’s housing exemption, warning it could weaken renters’ ability to bring claims over undisclosed fees. After extensive debate over variable pricing, sales taxes, enforcement, and the scope of the bill, Senator Morris moved to defer HB 617, and the committee agreed without objection.
The committee also heard HB 797, which would create a “Bayou Gold” certification program for certain gold vendors and transactional gold products. The sponsor said the program would encourage vendors to keep gold insured, segregated, and closer to Louisiana consumers, with the Treasury administering the certification through participant fees. Several senators and an outside witness raised concerns that the state seal could be mistaken for an endorsement, could create liability or consumer confusion, and would favor a narrow set of vendors. Despite opposition, the committee reported HB 797 favorably, with members noting it still had to go to Finance. Later, the committee advanced HB 1186, which would create a more uniform statewide building code and licensing system for inspectors, add disciplinary authority, and impose a small permit fee to support the program, and HB 1222, which would let LED develop a grocery initiative to address food deserts and food insecurity. The meeting concluded with the committee hearing HB 1256 on abandoned digital assets, which would require dormant digital assets to be held in original form for three years so owners can reclaim them.
LA
Transcript Highlights:
- And I’m happy to answer. clinical decision-making rather than a universal requirement.
- So frankly, the clinical trials... FDA acknowledged that.
- So frankly, the clinical trials for these drugs were a travesty.
- So the FDA licensed drugs that never underwent adequate clinical trials, and in the state of Louisiana
- passed a law requiring that drug that never underwent adequate clinical trials for sixth grade and seventh
Committee:
House Education
Summary:
The committee first heard HB 1079 by Rep. Boudreaux, which would allow charter schools to give enrollment preference to children who attended a licensed early learning center operated by the charter school or under an articulation agreement. An amendment expanded the preference to include children of active-duty military members, foster children, and children in court-ordered custody situations, and a second amendment clarified that the preference is permissive. Supporters said the bill would improve continuity from preschool to kindergarten and encourage more early learning centers. The committee adopted the amendments and reported HB 1079 as amended.
The committee then took up HB 737 by Vice Chair Amedee, which would remove the state requirement that students show proof of meningococcal vaccination for school or post-secondary entry. The author argued the bill aligns state law with updated CDC guidance and preserves parental choice and physician consultation, while opponents, including pediatricians, public health advocates, and meningitis survivors, warned that removing the requirement would lower vaccination rates and increase the risk of severe illness or death. After extensive testimony and questions, the committee voted 4-8 against the motion to report the bill, so HB 737 failed.
Next, the committee considered HB 628 by Rep. Landry, as substituted, to allow school boards and the Department of Education to work with licensed early learning centers to operate micro centers at schools, including dual licensing at one location. Supporters said it would expand access for three-year-olds, improve school readiness, and help families and the workforce. The substitute was adopted, and the bill was reported by substitute without objection.
Finally, the committee heard HB 1008 by Rep. Owen, which would prohibit public post-secondary institutions from retaliating against faculty for disclosing certain violations or exercising academic freedom and free speech. The author and a professor witness said the bill would protect open inquiry and reduce self-censorship in higher education. The committee adopted two amendments to clarify academic freedom and tighten remedies; the transcript cuts off before any final vote on the bill.
LA
Transcript Highlights:
- We protect the clinical decision-making rather than a universal requirement.
- So frankly, the clinical trials... FDA acknowledged that.
- So frankly, the clinical trials for these drugs were a travesty.
- So the FDA licensed drugs that never underwent adequate clinical trials, and in the state of Louisiana
- passed a law requiring that drug that never underwent adequate clinical trials for sixth grade and seventh
Committee:
House Education
AZ
Arizona 2026 Regular Session
01/26/2026 - House Health & Human Services
House Health & Human Services Committee of Reference
Transcript Highlights:
- Different agents being studied, much of these in Arizona, over 180 different clinical trials.
- That clinical trial would... So I entered into a clinical trial.
- That clinical trial was for the drug that they were just talking about, lecanemab.
- I continued with the clinical trial, and that led to FDA approvals, not only the trial drug, but diagnosis
- Not everyone can be in a clinical trial.
Summary:
The committee began with a presentation from the Alzheimer’s Association Desert Southwest Chapter and Dr. Anna Burke of Barrow Neurological Institute on the growing impact of Alzheimer’s and dementia in Arizona, the need for earlier diagnosis, better provider education, caregiver support, and continued research funding. They described current gaps in training and access to specialists, but also highlighted new therapies, lifestyle interventions, and Arizona-based research efforts. Members expressed support and optimism, but no action was taken on the presentation.
The committee then heard HB 2202, which appropriates $300,000 from the general fund over fiscal years 2027 through 2029 for a dementia care tele-mentoring grant program through the Department of Health Services. Supporters, including the Alzheimer’s Association, a dementia specialist, and a patient advocate, said the program would help primary care providers diagnose dementia earlier and improve care. The bill was passed out of committee on an 11-0 vote.
Next, the committee took up HB 2251, the midwifery bill, which would authorize certain licensed midwives to dispense and administer specified medications and devices, require liability insurance disclosure and annual reporting, and create a Midwifery Advisory Committee. A committee amendment removed some medications and renamed the bill the Jordan and MacTerry Act. ACOG and the Arizona Osteopathic Medical Association opposed the bill as drafted, citing concerns about oversight, peer review, and the medication list, while licensed midwives and other supporters argued the bill would improve safety, transparency, and alignment with national standards. The bill was held for further stakeholder work, with members indicating more amendments were likely.
The committee then heard HB 2252, which would allow certified nurse midwives, certified professional midwives, or licensed midwives to accompany a patient in a ground ambulance during an out-of-hospital birth if approved by medical direction. Supporters described cases where continued midwife involvement during transport helped newborns and mothers, while firefighters and EMS representatives opposed the bill as written, saying it created ambiguity about command and scene control and could raise safety concerns. The chair said the bill would be held for further stakeholder meetings and possible language changes. After a recess, the committee reconvened for presentations on federal Medicaid and rural health funding impacts, beginning with JLBC’s overview of H.R. 1’s Medicaid provisions and the rural health transformation grant program.
TX
Texas 89th Regular
Senate Committee on Health and Human Services Apr 15th, 2025
Health & Human Services
Transcript Highlights:
- The agency operates four clinics in South Texas and one mobile health unit.
- trials.
- So there's a five percent chance when you're at phase one clinical trial.
- You know, we've had to, you know, the companies have closed the clinical trials, but we have several
- And so I'm hoping that you have some trials and some grants being sought to look at this.
Bills:
SB623 , SB1266 , SB1310 , SB1373 , SB1580 , SB1952 , SB2032 , SB2269 , SB2544 , SB2653 , SB2796
Committee:
Senate Health & Human Services
CA
Transcript Highlights:
- Safety-net hospitals and clinics.
- This issue is repeating itself at clinics across the state, This issue is repeating itself at clinics
- Usually it's by plea or a jury trial, that the ...or a jury trial, that the death certificate should
- There are more than 3,000 clinical nurse specialists in California.
- That there are more than 3,000 clinical nurse specialists in California.
Committee:
Senate Health